Market Overview:
The global infant clinical nutrition market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of malnutrition, rising awareness about the benefits of early childhood nutrition, and growing demand for premium-quality products. The oral administration segment is expected to dominate the market in terms of revenue share during the forecast period. This can be attributed to factors such as ease of use and low cost as compared with other modes of administration. The hospital application segment is expected to account for a majority share in terms of revenue during the forecast period owing to rising prevalence rates of malnutrition among hospitalized infants across regions.
Product Definition:
Infant Clinical Nutrition is a branch of nutrition that specializes in the nutritional needs of infants and young children. It is important because proper nutrition during the early years can have a lasting impact on health throughout life.
Oral administration:
Oral administration is the feeding of a drug or supplement via the mouth. The substance being administered may be placed in a pill, liquid, suspension or colloidal dispersion and may also be mixed with food. It can be used for both therapeutic and prophylactic purposes.
Enteral administration:
Enteral administration is the process of feeding a semi-solid or liquid formula to an infant through a tube inserted in the baby's stomach. The nutrition is administered through a pump, which can be set to deliver nutrients at specific times and intervals according to need. Enteral feeding formulas are specially formulated for infants who cannot receive adequate nutrients from breast milk or maternal diet.
Application Insights:
Based on application, the market is segmented into hospital, nursery garden and others. The hospital segment dominated the global infant clinical nutrition market in 2017 owing to increasing number of premature births and high prevalence of underweight babies across the globe. In addition, a rise in adoption of artificial milk for infants has also increased demand for clinical nutrition products in hospitals.
The nursery garden segment is expected to witness lucrative growth over the forecast period due to growing awareness among parents regarding appropriate feeding habits for their baby¢â‚¬â„¢s first teeth and solid food intake required by them. Furthermore, increasing availability of baby care products including formula milk pouches at an affordable price will boost industry growth further during this period as well.
Regional Analysis:
North America dominated the global infant clinical nutrition market in 2017. The region is expected to maintain its position during the forecast period as well. This can be attributed to various factors such as favorable reimbursement policies, increasing awareness about infant feeding and nutritional requirements, presence of target population with high disposable income coupled with easy access to healthcare facilities. Moreover, government initiatives for improving maternal health are anticipated to fuel market growth over the forecast period.
Asia Pacific is estimated to witness lucrative growth over the next eight years owing to rising disposable income and growing demand for baby food products along with supportive government initiatives pertaining towards infant formula production & distribution system in emerging economies including China & India which will drive industry expansion over this period (2018-2030). Furthermore, availability of raw materials including soybean at low cost coupled with easy accessibility of land will boost production output thereby driving regional demand further (2018-2030).
Growth Factors:
- Increasing awareness about the benefits of infant clinical nutrition products among parents and caregivers.
- Rising disposable income of parents, which enables them to spend more on quality infant clinical nutrition products.
- Growing number of working mothers, who are increasingly looking for convenient and healthy options for their infants' diet.
- Proliferation of e-commerce platforms that offer a wide range of infant clinical nutrition products at competitive prices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Infant Clinical Nutrition Market Research Report
By Type
Oral administration, Enteral administration, Intravenous administration
By Application
Hospital, Nursery Garden, Other
By Companies
Abbott, Baxter International, Fresenius Kabi, Groupe Danone, Nutricia North America, Mead Johnson Nutrition, Meiji, Nestle Health Science, B. Braun Melsungen, Claris Lifesciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Infant Clinical Nutrition Market Report Segments:
The global Infant Clinical Nutrition market is segmented on the basis of:
Types
Oral administration, Enteral administration, Intravenous administration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Nursery Garden, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Baxter International
- Fresenius Kabi
- Groupe Danone
- Nutricia North America
- Mead Johnson Nutrition
- Meiji
- Nestle Health Science
- B. Braun Melsungen
- Claris Lifesciences
Highlights of The Infant Clinical Nutrition Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral administration
- Enteral administration
- Intravenous administration
- By Application:
- Hospital
- Nursery Garden
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infant Clinical Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infant clinical nutrition is the study of how to provide optimal nutrition for infants and young children from birth through age 2 years. This includes understanding the role of food in infant development, identifying nutritional needs during different stages of growth and development, and providing guidance on selecting appropriate foods.
Some of the major players in the infant clinical nutrition market are Abbott, Baxter International, Fresenius Kabi, Groupe Danone, Nutricia North America, Mead Johnson Nutrition, Meiji, Nestle Health Science, B. Braun Melsungen, Claris Lifesciences.
The infant clinical nutrition market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Infant Clinical Nutrition Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Infant Clinical Nutrition Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Infant Clinical Nutrition Market - Supply Chain
4.5. Global Infant Clinical Nutrition Market Forecast
4.5.1. Infant Clinical Nutrition Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Infant Clinical Nutrition Market Size (000 Units) and Y-o-Y Growth
4.5.3. Infant Clinical Nutrition Market Absolute $ Opportunity
5. Global Infant Clinical Nutrition Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Infant Clinical Nutrition Market Size and Volume Forecast by Type
5.3.1. Oral administration
5.3.2. Enteral administration
5.3.3. Intravenous administration
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Infant Clinical Nutrition Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Infant Clinical Nutrition Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Nursery Garden
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Infant Clinical Nutrition Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Infant Clinical Nutrition Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Infant Clinical Nutrition Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Infant Clinical Nutrition Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Infant Clinical Nutrition Demand Share Forecast, 2019-2026
9. North America Infant Clinical Nutrition Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Infant Clinical Nutrition Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Infant Clinical Nutrition Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Nursery Garden
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Infant Clinical Nutrition Market Size and Volume Forecast by Type
9.7.1. Oral administration
9.7.2. Enteral administration
9.7.3. Intravenous administration
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Infant Clinical Nutrition Demand Share Forecast, 2019-2026
10. Latin America Infant Clinical Nutrition Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Infant Clinical Nutrition Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Infant Clinical Nutrition Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Nursery Garden
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Infant Clinical Nutrition Market Size and Volume Forecast by Type
10.7.1. Oral administration
10.7.2. Enteral administration
10.7.3. Intravenous administration
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Infant Clinical Nutrition Demand Share Forecast, 2019-2026
11. Europe Infant Clinical Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Infant Clinical Nutrition Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Infant Clinical Nutrition Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Nursery Garden
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Infant Clinical Nutrition Market Size and Volume Forecast by Type
11.7.1. Oral administration
11.7.2. Enteral administration
11.7.3. Intravenous administration
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Infant Clinical Nutrition Demand Share, 2019-2026
12. Asia Pacific Infant Clinical Nutrition Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Infant Clinical Nutrition Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Infant Clinical Nutrition Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Nursery Garden
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Infant Clinical Nutrition Market Size and Volume Forecast by Type
12.7.1. Oral administration
12.7.2. Enteral administration
12.7.3. Intravenous administration
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Infant Clinical Nutrition Demand Share, 2019-2026
13. Middle East & Africa Infant Clinical Nutrition Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Infant Clinical Nutrition Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Infant Clinical Nutrition Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Nursery Garden
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Infant Clinical Nutrition Market Size and Volume Forecast by Type
13.7.1. Oral administration
13.7.2. Enteral administration
13.7.3. Intravenous administration
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Infant Clinical Nutrition Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Infant Clinical Nutrition Market: Market Share Analysis
14.2. Infant Clinical Nutrition Distributors and Customers
14.3. Infant Clinical Nutrition Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Kabi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Groupe Danone
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nutricia North America
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mead Johnson Nutrition
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Meiji
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nestle Health Science
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. B. Braun Melsungen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Claris Lifesciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook